Frey FJ - Search Results

1

The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane.

Odermatt A, Arnold P, Stauffer A, Frey BM, Frey FJ. Odermatt A, et al. Among authors: frey bm, frey fj. J Biol Chem. 1999 Oct 1;274(40):28762-70. doi: 10.1074/jbc.274.40.28762. J Biol Chem. 1999. PMID: 10497248 Free article.

2

In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3.

Nawrocki AR, Goldring CE, Kostadinova RM, Frey FJ, Frey BM. Nawrocki AR, et al. Among authors: frey bm, frey fj. J Biol Chem. 2002 Apr 26;277(17):14647-56. doi: 10.1074/jbc.M111549200. Epub 2002 Feb 15. J Biol Chem. 2002. PMID: 11850421 Free article.

3

Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.

Stauffer AT, Rochat MK, Dick B, Frey FJ, Odermatt A. Stauffer AT, et al. Among authors: frey fj. J Biol Chem. 2002 Jul 19;277(29):26286-92. doi: 10.1074/jbc.M201556200. Epub 2002 May 15. J Biol Chem. 2002. PMID: 12015312 Free article.

4

Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+.

Arnold P, Tam S, Yan L, Baker ME, Frey FJ, Odermatt A. Arnold P, et al. Among authors: frey fj. Mol Cell Endocrinol. 2003 Mar 28;201(1-2):177-87. doi: 10.1016/s0303-7207(02)00304-0. Mol Cell Endocrinol. 2003. PMID: 12706305

5

Pharmacology of 11 beta-hydroxysteroid dehydrogenase.

Frey FJ, Escher G, Frey BM. Frey FJ, et al. Among authors: frey bm. Steroids. 1994 Feb;59(2):74-9. doi: 10.1016/0039-128x(94)90079-5. Steroids. 1994. PMID: 8191551 Review.

6

Reduced 11beta-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy.

Escher G, Vogt B, Beck T, Guntern D, Frey BM, Frey FJ. Escher G, et al. Among authors: frey bm, frey fj. Endocrinology. 1998 Apr;139(4):1533-9. doi: 10.1210/endo.139.4.5891. Endocrinology. 1998. PMID: 9528931

7

Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.

Vogt B, Dick B, N'Gankam V, Frey FJ, Frey BM. Vogt B, et al. Among authors: frey bm, frey fj. J Clin Endocrinol Metab. 1999 Feb;84(2):811-4. doi: 10.1210/jcem.84.2.5569. J Clin Endocrinol Metab. 1999. PMID: 10022459

8

Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis.

Ackermann D, Vogt B, Escher G, Dick B, Reichen J, Frey BM, Frey FJ. Ackermann D, et al. Among authors: frey bm, frey fj. Hepatology. 1999 Sep;30(3):623-9. doi: 10.1002/hep.510300303. Hepatology. 1999. PMID: 10462366

9

11 beta-Hydroxysteroid dehydrogenase: pathophysiology.

Vogt B, Frey BM, Frey FJ. Vogt B, et al. Among authors: frey bm, frey fj. Adv Nephrol Necker Hosp. 1999;29:127-48. Adv Nephrol Necker Hosp. 1999. PMID: 10561741 Review. No abstract available.

10

A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.

Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P. Odermatt A, et al. Among authors: frey bm, frey fj. J Clin Endocrinol Metab. 2001 Mar;86(3):1247-52. doi: 10.1210/jcem.86.3.7334. J Clin Endocrinol Metab. 2001. PMID: 11238516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters